Insight Therapeutics, LLC, and Brown University are undertaking a large-scale quality improvement and comparative eﬀectiveness study to evaluate the impact of the annual inﬂuenza vaccine choice on nursing home residents’ hospitalization risk for the 2019-2020 inﬂuenza season.
Eligible nursing homes allocated to one of two approved vaccines
• Easy to enroll
• Vaccine provided at no cost for residents and staﬀ
• Simpliﬁed data collection
• Compensation is available
For more information, please call us at 757-625-6040 or email at email@example.com.
To complete an online screening form, click here.